HOME >> MEDICINE >> NEWS
Mayo Clinic identifies key cellular process in prostate and other cancers

ROCHESTER, Minn. -- Mayo Clinic researchers are the first to identify an interaction between two cellular proteins -- Skp2 and FOXO1 -- that is important for the growth and survival of cancer cells. Researchers also show that this interaction can be chemically reversed to stop cancer tumor growth -- a strategy that may lead to new and better cancer treatments.

Their report appears as an electronic advance article of PNAS, the Proceedings of the National Academy of Sciences ( http://www.pnas.org/cgi/reprint/102/5/1649). The research was performed on human cells in the laboratory and was found effective against human cancer cells. Researchers say it will be at least a year before the discovery can be applied in a human clinical trial.

The Findings

For the first time, the Mayo Clinic research group provides laboratory evidence to describe a new mechanism by which cells lose the protection of tumor suppressors -- and therefore become vulnerable to cancerous cell growth. In particular, they show that Skp2 is the cellular player that interacts with FOXO1 by tagging it for destruction. This degradation of FOXO1 by high levels of Skp2, in turn, abolishes the ability of FOXO1 to suppress tumors. The result of their experiment indicates that human prostate cancer grows without the protection of the tumor suppressor protein FOXO1. Importantly, they also show that this loss of function can be reversed -- even in the presence of high levels of Skp2, by using chemicals that inhibit protein destruction, and thus block Skp2's action against FOXO1.

Significance of the Finding

"The major finding of our studies is that the tumor suppression function of FOXO1 is abolished due to Skp2-mediated protein degradation," says Haojie Huang, Ph.D., the urology researcher who performed the study. Co-investigator Donald J. Tindall, Ph.D., adds, "We've discovered a viable therapeutic t
'"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
14-Feb-2005


Page: 1 2 3

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Clinical breast examination offers modest benefit to breast cancer screening program
7. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
8. Clinicians report missing patient information is common
9. Mayo Clinic discovers a key to low metabolism and major factor in obesity
10. Clinical trial of Etanercept for Wegeners disease shows no benefit
11. Mayo Clinic researchers identify new form of muscular dystrophy in adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2019)... ... September 12, 2019 , ... ... and national scale in two recent and well-renowned listing publications, the Inc. 5000 ... businesses for the 2019 year. , Dr. Jeffrey Donaldson, CEO and owner ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global Education Group (Global), ... (CME) provider, is the official accreditor for PAINWeek, the largest US pain conference ... topics, as it has done for the past ten years. In addition, the ...
(Date:9/11/2019)... ... , ... Autopsies don’t lie. They report the causes of death as ... harms the heart. It increases risks of heart attack and death. Autopsies ... damage occurs. , An August 1, 2019 article in U.S. News ...
(Date:9/11/2019)... OAK, Mich. (PRWEB) , ... September 10, 2019 , ... ... The new office is location at 32686 Woodward Ave, Suite 103, Royal Oak, ... mile. , “Our Royal Oak location offers comprehensive women’s health services in a contemporary, ...
(Date:9/11/2019)... , ... September 10, 2019 , ... ... critical support to the most vulnerable communities impacted by Hurricane Dorian. , ... South Carolina, the Episcopal Diocese of Georgia, and the Episcopal Farmworker Ministry, Episcopal ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... September 14, 2019 , ... On September 11, 2019, after ... jury in Middlesex County found Johnson & Johnson liable for causing the Plaintiffs’ ... caused by asbestos-containing J&J talc products. , A unanimous jury found ...
(Date:9/12/2019)... LAKE CITY (PRWEB) , ... September 12, 2019 ... ... USA are collaborating to help make the services of CPESN’s clinically integrated network ... providers and payers. CPESN USA’s participating pharmacies provide high quality clinical service ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... analysis, with many companies developing technologies to evaluate medical images. In fact, image ... understands the approaches the FDA is taking to AI-based image analysis, one will ...
Breaking Medicine Technology:
Cached News: